Features of interleukin levels-1 and -6 in patients with obstructive sleep apnea and metabolic syndrome after COVID-19

When assessing the relationship between obstructive sleep apnea syndrome (OSA) and metabolic syndrome (MS) in patients with arterial hypertension (AH), it becomes clear that they demonstrate a mutual causal relationship with each other and that inflammation, including after COVID-19, affects this bidirectional interaction of organs and leads to subsequent organ damage. The aim of the study was to evaluate the levels of interleukins -1 and -6 in patients with obstructive sleep apnea and metabolic syndrome with arterial hypertension who had suffered from COVID-19. Materials and methods: 92 male patients were examined. The age of the subjects ranged from 30 to 75 years. Depending on the presence or absence of a history of coronavirus infection, patients were divided into 2 groups: the number of subjects in group 1 (n= 51), in the second group (n=41). All patients with grade 1-3 hypertension, with the achieved target blood pressure level. The age of the subjects was 30-75 years. All patients underwent: collection of complaints and anamnesis, assessment of body mass index (BMI); determination of the lipid spectrum, blood glucose, glomerular filtration rate. The ELISA method determined interleukins 1, 6. Instrumental studies were carried out: cardiorespiratory monitoring. Results. In patients of group 1 who had COVID-19, the levels of IL-1 and IL-6 were significantly higher compared to group 2 (p=0.034 and p=0.041, respectively). An intragroup analysis in group 1 revealed statistically significant correlations between BMI and episodes of apnea over 40 seconds (r=0.89; p=0.012), no statistically significant differences were obtained between BMI and IL-1 and IL-6 levels (p>0.05). An intragroup analysis in group 2 revealed a direct relationship between IAG and IL-1 levels (r=0.88; p=0.017).

Authors

Institutions

Publication Details

Journal
Экспериментальная и клиническая гастроэнтерология
Published
2026-11-18
DOI
https://doi.org/10.31146/1682-8658-ecg-248-4-36-41
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Features of interleukin levels-1 and -6 in patients with obstructive sleep apnea and metabolic syndrome after COVID-19

Токарев Сергей Александрович, L. Yu. Shvan, И. В. Губарева
2 links
Экспериментальная и клиническая гастроэнтерология
Obstructive Sleep Apnea Research
article

Features of interleukin levels-1 and -6 in patients with obstructive sleep apnea and metabolic syndrome after COVID-19

Токарев Сергей Александрович, L. Yu. Shvan, И. В. Губарева
article en

Abstract

When assessing the relationship between obstructive sleep apnea syndrome (OSA) and metabolic syndrome (MS) in patients with arterial hypertension (AH), it becomes clear that they demonstrate a mutual causal relationship with each other and that inflammation, including after COVID-19, affects this bidirectional interaction of organs and leads to subsequent organ damage. The aim of the study was to evaluate the levels of interleukins -1 and -6 in patients with obstructive sleep apnea and metabolic syndrome with arterial hypertension who had suffered from COVID-19. Materials and methods: 92 male patients were examined. The age of the subjects ranged from 30 to 75 years. Depending on the presence or absence of a history of coronavirus infection, patients were divided into 2 groups: the number of subjects in group 1 (n= 51), in the second group (n=41). All patients with grade 1-3 hypertension, with the achieved target blood pressure level. The age of the subjects was 30-75 years. All patients underwent: collection of complaints and anamnesis, assessment of body mass index (BMI); determination of the lipid spectrum, blood glucose, glomerular filtration rate. The ELISA method determined interleukins 1, 6. Instrumental studies were carried out: cardiorespiratory monitoring. Results. In patients of group 1 who had COVID-19, the levels of IL-1 and IL-6 were significantly higher compared to group 2 (p=0.034 and p=0.041, respectively). An intragroup analysis in group 1 revealed statistically significant correlations between BMI and episodes of apnea over 40 seconds (r=0.89; p=0.012), no statistically significant differences were obtained between BMI and IL-1 and IL-6 levels (p>0.05). An intragroup analysis in group 2 revealed a direct relationship between IAG and IL-1 levels (r=0.88; p=0.017).

Экспериментальная и клиническая гастроэнтерология(4)
Samara State Medical University (RU)
Good health and well-being
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon